Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/U.S. Stem Cell, Inc./ NT 10-K

SEC Filing · NT 10-K

U.S. Stem Cell, Inc.

USRMOTCEQUITYCurrent

SEC Filing

Filed Mar 31, 2023Accepted Mar 31, 2023, 5:00 AM EDTCIK 1388319Accession 0001185185-23-000280
View company →Permanent SEC source ↗
Share

Company context

Current securities

USRMOTC · EQUITY · Current

Recent company filings

  1. NT 10-Q filingMay 15, 2023
  2. 10-K filingApr 14, 2023
  3. 10-Q filingNov 9, 2022
  4. 10-Q filingAug 22, 2022
  5. NT 10-Q filingAug 15, 2022

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗